BioCentury
ARTICLE | Company News

Daiichi Sankyo sales and marketing update

January 5, 2015 8:00 AM UTC

Daiichi’s Daiichi Sankyo Espha Co. Ltd. subsidiary launched generic versions of levofloxacin, candesartan cilexetil and IV oxaliplatin in Japan. Daiichi markets levofloxacin, a synthetic broad-spectru...